Minocycline Levels in Tears of Patients With Active Trachoma

Khalid F. Tabbara, Hendrik Cooper

Research output: Contribution to journalArticle

Abstract

We determined minocycline levels in human tears and plasma samples using high-performance liquid chromatography. In the first study, we determined the trough tear and plasma levels of minocycline in patients with active trachoma 24 hours after an oral dose. After a single dose of minocycline, the mean concentration of the drug in tear samples was 189 ± 58 ng/mL and corresponding plasma levels were 578 ± 290 ng/mL. In a second study, we monitored the pharmacokinetics of the drug in tear and plasma samples of healthy nonfasting adults. Tear and plasma samples were collected at 1 through 6, 12, 24, 48, 72, and 96 hours. The pharmacokinetics study revealed that 48 hours following a single 200-mg dose of minocycline, the mean tear level of minocycline was 68 ng/mL, which is above the in vitro minimal inhibitory concentration required for Chlamydia trachomatis and other susceptible organisms.

Original languageEnglish (US)
Pages (from-to)93-95
Number of pages3
JournalArchives of Ophthalmology
Volume107
Issue number1
DOIs
StatePublished - 1989
Externally publishedYes

Fingerprint

Trachoma
Minocycline
Tears
Pharmacokinetics
Chlamydia trachomatis
Pharmaceutical Preparations
High Pressure Liquid Chromatography

ASJC Scopus subject areas

  • Ophthalmology

Cite this

Minocycline Levels in Tears of Patients With Active Trachoma. / Tabbara, Khalid F.; Cooper, Hendrik.

In: Archives of Ophthalmology, Vol. 107, No. 1, 1989, p. 93-95.

Research output: Contribution to journalArticle

Tabbara, Khalid F. ; Cooper, Hendrik. / Minocycline Levels in Tears of Patients With Active Trachoma. In: Archives of Ophthalmology. 1989 ; Vol. 107, No. 1. pp. 93-95.
@article{6bba818b42a94cd3b4e3e5a71674f0c3,
title = "Minocycline Levels in Tears of Patients With Active Trachoma",
abstract = "We determined minocycline levels in human tears and plasma samples using high-performance liquid chromatography. In the first study, we determined the trough tear and plasma levels of minocycline in patients with active trachoma 24 hours after an oral dose. After a single dose of minocycline, the mean concentration of the drug in tear samples was 189 ± 58 ng/mL and corresponding plasma levels were 578 ± 290 ng/mL. In a second study, we monitored the pharmacokinetics of the drug in tear and plasma samples of healthy nonfasting adults. Tear and plasma samples were collected at 1 through 6, 12, 24, 48, 72, and 96 hours. The pharmacokinetics study revealed that 48 hours following a single 200-mg dose of minocycline, the mean tear level of minocycline was 68 ng/mL, which is above the in vitro minimal inhibitory concentration required for Chlamydia trachomatis and other susceptible organisms.",
author = "Tabbara, {Khalid F.} and Hendrik Cooper",
year = "1989",
doi = "10.1001/archopht.1989.01070010095034",
language = "English (US)",
volume = "107",
pages = "93--95",
journal = "JAMA Ophthalmology",
issn = "2168-6165",
publisher = "American Medical Association",
number = "1",

}

TY - JOUR

T1 - Minocycline Levels in Tears of Patients With Active Trachoma

AU - Tabbara, Khalid F.

AU - Cooper, Hendrik

PY - 1989

Y1 - 1989

N2 - We determined minocycline levels in human tears and plasma samples using high-performance liquid chromatography. In the first study, we determined the trough tear and plasma levels of minocycline in patients with active trachoma 24 hours after an oral dose. After a single dose of minocycline, the mean concentration of the drug in tear samples was 189 ± 58 ng/mL and corresponding plasma levels were 578 ± 290 ng/mL. In a second study, we monitored the pharmacokinetics of the drug in tear and plasma samples of healthy nonfasting adults. Tear and plasma samples were collected at 1 through 6, 12, 24, 48, 72, and 96 hours. The pharmacokinetics study revealed that 48 hours following a single 200-mg dose of minocycline, the mean tear level of minocycline was 68 ng/mL, which is above the in vitro minimal inhibitory concentration required for Chlamydia trachomatis and other susceptible organisms.

AB - We determined minocycline levels in human tears and plasma samples using high-performance liquid chromatography. In the first study, we determined the trough tear and plasma levels of minocycline in patients with active trachoma 24 hours after an oral dose. After a single dose of minocycline, the mean concentration of the drug in tear samples was 189 ± 58 ng/mL and corresponding plasma levels were 578 ± 290 ng/mL. In a second study, we monitored the pharmacokinetics of the drug in tear and plasma samples of healthy nonfasting adults. Tear and plasma samples were collected at 1 through 6, 12, 24, 48, 72, and 96 hours. The pharmacokinetics study revealed that 48 hours following a single 200-mg dose of minocycline, the mean tear level of minocycline was 68 ng/mL, which is above the in vitro minimal inhibitory concentration required for Chlamydia trachomatis and other susceptible organisms.

UR - http://www.scopus.com/inward/record.url?scp=0024558817&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0024558817&partnerID=8YFLogxK

U2 - 10.1001/archopht.1989.01070010095034

DO - 10.1001/archopht.1989.01070010095034

M3 - Article

VL - 107

SP - 93

EP - 95

JO - JAMA Ophthalmology

JF - JAMA Ophthalmology

SN - 2168-6165

IS - 1

ER -